Journal
CHEMICAL BIOLOGY & DRUG DESIGN
Volume 86, Issue 5, Pages 951-960Publisher
WILEY
DOI: 10.1111/cbdd.12549
Keywords
biological screening; drug development; gene expression; mechanism-based drug design; therapeutic target
Ask authors/readers for more resources
Mycobacterium tuberculosis is considered one of the most successful pathogens and multidrug-resistant tuberculosis, a disease that urgently requires new chemical entities to be developed for treatment. There are currently several new molecules under clinical investigation in the tuberculosis (TB) drug development pipeline. However, the complex lifestyle of M. tuberculosis within the host presents a barrier to the development of new drugs. In this review, we highlight the reasons that make TB drug discovery and development challenging as well as providing solutions, future directions and alternative approaches to new therapeutics for TB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available